CD200 Expression in Neuroendocrine Neoplasms.

Conclusions: CD200 is a relatively sensitive marker of neuroendocrine neoplasms and represents a potential therapeutic target in these difficult-to-treat malignancies.
PMID: 28821198 [PubMed - in process]

Source: American Journal of Clinical Pathology - August 20, 2017 Category: Pathology Authors: Love JE, Thompson K, Kilgore MR, Westerhoff M, Murphy CE, Papanicolau-Sengos A, McCormick KA, Shankaran V, Vandeven N, Miller F, Blom A, Nghiem PT, Kussick SJ Tags: Am J Clin Pathol Source Type: research